BioAdaptives Launches MyndMed Cognitive-Support Supplement Amid Strong Demand
April 28th, 2026 2:15 PM
By: Newsworthy Staff
BioAdaptives has commercially launched MyndMed, a dietary supplement aimed at enhancing memory and focus, following positive testing and high early demand.
BioAdaptives, Inc. (OTCMKTS: BDPT) announced the commercial launch of MyndMed™, a next-generation dietary supplement designed to enhance memory, focus, and overall brain performance. The company reported extensive testing with highly positive user feedback and is scaling production and expanding distribution to meet anticipated high demand beginning in November.
Formulated to support cognitive function across short-, mid-, and long-term pathways, MyndMed™ delivers what the company calls “Mental Armor for Modern Minds™” through clinically studied ingredients that promote alertness, neuroplasticity, and cellular energy balance. The supplement is manufactured in the U.S. in cGMP-certified facilities and third-party tested for purity.
MyndMed™ is available nationwide at www.MyndMed.com. For more information about BioAdaptives, visit www.bioadaptives.com. The full press release is available at https://nnw.fm/Lehwp.
This launch marks a significant milestone for BioAdaptives, which pioneers and markets health and wellness products with science-driven formulations. Through its ClearMynd division, the company is developing products to advance cognitive performance, recovery, and enduring brain health.
Source Statement
This news article relied primarily on a press release disributed by InvestorBrandNetwork (IBN). You can read the source press release here,
